MicroRNA-6077 enhances the sensitivity of patients-derived lung adenocarcinoma cells to anlotinib by repressing the activation of glucose transporter 1 pathway. [electronic resource]
Producer: 20200908Description: 109391 p. digitalISSN:- 1873-3913
- A549 Cells
- Adenocarcinoma of Lung -- drug therapy
- Animals
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Dendritic Cells -- drug effects
- Drug Resistance, Neoplasm
- Glucose Transporter Type 1 -- metabolism
- Humans
- Indoles -- pharmacology
- Lung Neoplasms -- drug therapy
- Mice, Nude
- MicroRNAs -- physiology
- Quinolines -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.